States / West Virginia / HB 4626

HB 4626 Vetoed

Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber
House
Introduced
Jan 21, 2026
Last action
Mar 14, 2026 — Vetoed by Governor 4/1/2026 - Senate Journal
Session
2026
Momentum
5 · Stalled